Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses-Reference-Cited by-同舟云学术

Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses

Published:2005-09-23 Issue:6 Volume:118 Page:1508-1514
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ferguson Morag,Heath Alan,Johnes Suzanne,Pagliusi Sonia,Dillner Joakim,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. A controlled trial of a human papillomavirus type 16 vaccine;Koutsky;N Engl J Med,2002

2. Efficacy of a bivalent L1 virus-like particle vaccine in prevention with human papillomavirus types 16 and 18 in young women: a randomised controlled trial;Harper;Lancet,2004

3. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial;Villa;Lancet Oncol,2005

4. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine;Harro;J Natl Cancer Inst,2001

5. World Health Organization The current status of development of prophylactic vaccines against human papillomavirus infection http://www.who.int/vaccine_research/documents/en/ hpv1.pdf

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58;npj Vaccines;2024-09-10

2. Precision and correlation of ED50 and endpoint titer method in measuring HPV vaccine immunogenicity;Journal of Virological Methods;2023-06

3. Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals;Human Vaccines & Immunotherapeutics;2020-06-16

4. Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development;Vaccine;2018-08

5. High specific immune response to a bivalent anti-HPV vaccine in HIV-1-infected men in São Paulo, Brazil;Papillomavirus Research;2016-12